Company Filing History:
Years Active: 2015
Title: Marie Delporte: Innovator in Pharmaceutical Compositions
Introduction
Marie Delporte is a notable inventor based in Chartres, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. Her work focuses on innovative solutions that enhance the delivery of active substances in medical treatments.
Latest Patents
Marie Delporte holds a patent for "Sustained release formulations comprising GNRH analogues." This invention relates to pharmaceutical compositions designed for the controlled and sustained release of active substances, utilizing biodegradable polymers or copolymers. The patent emphasizes the importance of delivering peptides, hormones, and their analogs effectively, ensuring that patients receive optimal therapeutic benefits.
Career Highlights
Marie Delporte is associated with Ipsen Pharma S.a.s., a company known for its commitment to innovation in the pharmaceutical industry. Her role at Ipsen Pharma has allowed her to contribute to groundbreaking research and development efforts, particularly in the area of drug formulation.
Collaborations
Throughout her career, Marie has collaborated with esteemed colleagues such as Roland Cherif-Cheikh and Fédéric Lacombe. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to advancements in pharmaceutical technologies.
Conclusion
Marie Delporte's contributions to the field of pharmaceuticals through her innovative patent and collaborative efforts highlight her role as a key figure in advancing medical treatments. Her work continues to impact the industry positively, paving the way for future innovations.